OCS DIAMOND Trials Miss: A Trial Failure Wipes Out Months of Gains
OCS entered the weekend down 23% — a collapse driven by a single late-Friday announcement. The entire OCS story this week resolves to one event. After Friday's close, Oculis reported topline results from the DIAMOND-1…
